InVivo Therapeutics Receives Approval for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury

News   Apr 10, 2013

 
InVivo Therapeutics Receives Approval for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury
 
 
 

RELATED ARTICLES

Researchers Create Remote-Controlled Cancer Immunotherapy System

News

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

READ MORE

Heart-muscle Patches Created from Human Cells Improve Recovery from Heart Attacks

News

Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.

READ MORE

Innate Immune Cells Reprogrammed to Fight Tuberculosis

News

A cure has eluded scientists for more than a century but, now, a Montreal team of researchers may have discovered a new weapon to combat this global killer. The team is re-programing - or 'training' - immune cells to kill TB. These groundbreaking findings are published online today in the journal Cell.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE